APA (7th ed.) Citation

Roperch, J., Charbonnier, G., Figiel, S., Lamb, A., Mills, I., Hennion, C., . . . Cussenot, O. (2025). Multiple highly methylated CpG sites as potential epigenetic markers for the diagnosis of prostate cancer. Clinical Epigenetics, 17(1), 1. https://doi.org/10.1186/s13148-025-01930-z

Chicago Style (17th ed.) Citation

Roperch, Jean-Pierre, Guillaume Charbonnier, Sandy Figiel, Alastair Lamb, Ian Mills, Claude Hennion, Géraldine Cancel-Tassin, and Olivier Cussenot. "Multiple Highly Methylated CpG Sites as Potential Epigenetic Markers for the Diagnosis of Prostate Cancer." Clinical Epigenetics 17, no. 1 (2025): 1. https://doi.org/10.1186/s13148-025-01930-z.

MLA (9th ed.) Citation

Roperch, Jean-Pierre, et al. "Multiple Highly Methylated CpG Sites as Potential Epigenetic Markers for the Diagnosis of Prostate Cancer." Clinical Epigenetics, vol. 17, no. 1, 2025, p. 1, https://doi.org/10.1186/s13148-025-01930-z.